Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / cs
-
Total 13F shares
-
2,825,628
-
Share change
-
+2,796,995
-
Total reported value
-
$23,559,447
-
Put/Call ratio
-
11%
-
Price per share
-
$8.34
-
Number of holders
-
76
-
Value change
-
+$23,320,905
-
Number of buys
-
70
-
Number of sells
-
1
Institutional Holders of bluebird bio, Inc. - cs (BLUE) as of Q4 2024
As of 31 Dec 2024,
bluebird bio, Inc. - cs (BLUE) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,825,628 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, UBS Group AG, NATIONAL BANK OF CANADA /FI/, NORTHERN TRUST CORP, Avidity Partners Management LP, Lion Point Capital, LP, and PFM Health Sciences, LP.
This page lists
77
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.